Improved retention of patients starting antiretroviral treatment in karonga District, Northern Malawi, 2005-2012

Journal of Acquired Immune Deficiency Syndromes

Volumn 67, Issue 1, 2014, Pages

  Koole, Olivier ^a,b   Houben, Rein M G J ^a   Mzembe, Themba ^b   Van Boeckel, Thomas P ^c   Kayange, Michael ^d   Jahn, Andreas ^d,e   Chimbwandira, Frank ^d   Glynn, Judith R ^a   Crampin, Amelia C ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KARONGA PREVENTION STUDY   (Malawi)

^c PRINCETON UNIVERSITY   (United States)

^d MINISTRY OF HEALTH   (Malawi)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEVIRAPINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; AGE; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONFERENCE PAPER; DECENTRALIZATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CENTER; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALAWI; MALE; MEDICATION COMPLIANCE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; EPIDEMIOLOGY; HIV INFECTIONS; KAPLAN MEIER METHOD; PATIENT ATTITUDE; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; KAPLAN-MEIER ESTIMATE; LOST TO FOLLOW-UP; MALAWI; MALE; NEVIRAPINE; PATIENT ACCEPTANCE OF HEALTH CARE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84906088783     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000252     Document Type: Conference Paper

References (27)

1. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2013. 2013. Available at: http://www.unaids.org/en/media/unaids/contentassets/ documents/epidemiology/2013/gr2013/UNAIDS- Global-Report-2013-en.pdf. Accessed January 31, 2014.
2. WHO, UNICEF, UNAIDS. Global update on HIV treatment 2013: results, impact and opportunities. 2013. Available at: http://apps.who.int/iris/bitstream/ 10665/85326/1/9789241505734-eng.pdf. Accessed January 31, 2014.
3. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health. 2010;15(suppl 1):1-15.
4. Yu JK, Chen SC, Wang KY, et al. True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bull World Health Organ. 2007;85:550-554.
5. Chan AK, Mateyu G, Jahn A, et al. Outcome assessment of decentralization of antiretroviral therapy provision in a rural district of Malawi using an integrated primary care model. Trop Med Int Health. 2010;15 (suppl 1):90-97.
6. Giordano TP, Gifford AL, White AC Jr, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007;44:1493-1499.
7. Geng EH, Nash D, Kambugu A, et al. Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep. 2010;7:234-244.
8. Tweya H, Feldacker C, Estill J, et al. Are they really lost? "True" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi. PLoS One. 2013;8:e75761.
9. Lowrance DW, Makombe S, Harries AD, et al. A public health approach to rapid scale-up of antiretroviral treatment in Malawi during 2004-2006. JAcquir Immune Defic Syndr. 2008;49:287-293.
10. Gilks CF, Crowley S, Ekpini R, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 2006;368:505-510.
11. Weigel R, Estill J, Egger M, et al. Mortality and loss to follow-up in the first year of ART: Malawi national ART programme. AIDS. 2012;26: 365-373.
12. Floyd S, Molesworth A, Dube A, et al. Underestimation of HIV prevalence in surveys when some people already know their status, and ways to reduce the bias. AIDS. 2013;27:233-242.
13. Schouten EJ, Jahn A, Midiani D, et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet. 2011;378:282-284.
14. Houben RM, Van Boeckel TP, Mwinuka V, et al. Monitoring the impact of decentralised chronic care services on patient travel time in rural Africa-methods and results in Northern Malawi. Int J Health Geogr. 2012;11:49.
15. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4:e298.
16. McGuire M, Pinoges L, Kanapathipillai R, et al. Treatment initiation, program attrition and patient treatment outcomes associated with scale-up and decentralization of HIV care in rural Malawi. PLoS One. 2012;7: e38044.
17. Labhardt ND, Keiser O, Sello M, et al. Outcomes of antiretroviral treatment programmes in rural Lesotho: health centres and hospitals compared. J Int AIDS Soc. 2013;16:18616.
18. Cornell M, Grimsrud A, Fairall L, et al. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS. 2010;24:2263-2270.
19. Koole O, Kalenga L, Kiumbu M, et al. Retention in a NGO supported antiretroviral program in the Democratic Republic of Congo. PLoS One. 2012;7:e40971.
20. Charurat M, Oyegunle M, Benjamin R, et al. Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors. PLoS One. 2010;5:e10584.
21. Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS. 2004;18:887-895.
22. Ferradini L, Jeannin A, Pinoges L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet. 2006;367:1335-1342.
23. Calmy A, Pinoges L, Szumilin E, et al. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS. 2006;20:1163-1169.
24. Cornell M, Myer L, Kaplan R, et al. The impact of gender and income on survival and retention in a South African antiretroviral therapy programme. Trop Med Int Health. 2009;14:722-731.
25. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. 2013. Available at: http://www.who.int/iris/bitstream/10665/85321/1/ 9789241505727-eng.pdf. Accessed April 1, 2014.
26. Tenthani L, Haas AD, Tweya H, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ("Option B+") in Malawi. AIDS. 2014;28:589-598.
27. Douglas GP, Gadabu OJ, Joukes S, et al. Using touchscreen electronic medical record systems to support and monitor national scale-up of antiretroviral therapy in Malawi. PLoS Med. 2010;7:e1000319.